Aclaris Therapeutics Inc (ACRS)
SG&A Expense Growth
-10.31%
Quarterly · Period ending:
ACRS SG&A Expense Growth
Latest reported-10.31%period ending
Latest reported-10.31%period ending
ACRS Quarterly SG&A Growth (QoQ) (0.00% → -10.31%)
Latest values, visible window
High-resolution chart · PNG
ACRS sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -10.307% | |
| 20.929% | |
| 14.4734% | |
| -9.5618% | |
| -12.2658% | |
| 23.9201% | |
| -12.3651% | |
| 21.5176% | |
| -32.0281% | |
| -16.6788% | |
| 20.8297% | |
| -6.8257% | |
| -16.9966% | |
| 23.0059% | |
| 22.9314% | |
| -4.3128% | |
| -0.3935% | |
| -12.1561% | |
| 16.1231% | |
| 1.8569% | |
| 21.6076% | |
| -1.4697% | |
| 26.95% | |
| -30.743% | |
| -10.129% | |
| -6.1743% | |
| 5.1225% | |
| -58.5548% | |
| -15.8371% | |
| -8.3414% | |
| 9.5076% | |
| -5.4505% | |
| 8.552% | |
| 45.8722% | |
| 47.6302% | |
| 28.3254% | |
| 22.722% | |
| 10.1196% | |
| 28.3288% | |
| 15.7628% | |
| -12.5139% | |
| 50.1667% | |
| 94.8052% | |
| 53.4247% | |
| -9.9776% | |
| 62.7737% | |
| -3.0088% | |
| 23.7678% | |
| 0% | |
| 0% |